Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
Double-blind, randomized, placebo-controlled, multi-center clinical trial conducted to
evaluate levetiracetam as adjunctive therapy in children (4-16 years) with refractory partial
onset seizures.